Vaping: New challenges for cardiovascular disease prevention
Save for Later
To join the newsletters for the webinar series or for any questions e-mail KTHP@heartandstroke.ca
Vaping: New challenges for cardiovascular disease prevention
Recorded Thursday, January 23, 2020
Presenter
Andrew Pipe CM, BA, MD
Division of Prevention and Rehabilitation, University of Ottawa Heart Institute
Professor, Faculty of Medicine, University of Ottawa
Chair, Board of Directors, Heart & Stroke
Intended Audience
This webinar is intended for all health professionals caring for people with heart conditions, stroke or vascular cognitive impairment across all settings and stages of care (e.g. acute, rehabilitation, community); system leaders and funders involved in planning and service delivery; researchers; trainees from across health-related disciplines; as well as people experiencing these conditions, their families and caregivers. It is also suitable for members of the public who are interested in this topic.
About this presentation
Dr. Pipe is the chair of Heart & Stroke’s national board of directors and Canada’s foremost expert on smoking cessation. In this one-hour session he will speak to the impact vaping has on the health of people in Canada and will touch on what can be done to influence public policy around this contentious issue and open discussions in the clinical setting. This discussion will include a focus on the youth vaping trend and the concept of nicotine as a gateway drug. Dr. Pipe will discuss the challenges faced with vaping and the steps that need to be taken to combat this issue. In addition, the advantages and shortcomings of nicotine replacement therapy will be discussed. Join this important and timely webinar to learn about vaping and the associated risks and challenges for cardiovascular disease prevention from one of the top experts in the field.
Learning Objectives
Participants of this program will be able to:
1. Examine and explain the controversies surrounding vaping and the importance of influencing healthy public policy.
2. Describe the risks associated with vaping and the impact on cardiovascular disease prevention.
3. Discuss how to engage in meaningful discussion about vaping and smoking cessation with individuals.
4. Recognize the advantages and shortcomings of nicotine replacement therapy.
The following information was provided with permission of the speaker. The information is intended for use by healthcare professionals for reference and education only and is not intended to be a substitute for a physician’s advice, diagnosis or treatment. You should consult your physician for personal health matters.
Responses